search
Back to results

Effects of Behavioral Interventions on Weight Loss and Weight Maintenance

Primary Purpose

Behavior

Status
Withdrawn
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Behavioral interventions/modifications
Sponsored by
University of Pittsburgh
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Behavior focused on measuring weight loss, weight maintenance

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  1. Male or female aged 18 yrs or older
  2. BMI >40 kg/m2
  3. BMI between 35-40 kg/m2 with obesity-related co-morbidities including type 2 diabetes mellitus, hypertension, dyslipidemia. Type 2 Diabetes Mellitus defined by A1c >6.4% with or without oral hypoglycemic agents and with or without insulin therapy. Hypertension defined by blood pressure >140/80 mm of hg with or without antihypertensive therapy. Dyslipidemia defined as fasting lipid profile with one or more of the following abnormalities: serum cholesterol levels >200 mg/dl, serum triglyceride levels >150 mg/dl, HDL levels <50 mg/dl, LDL levels >100 mg/dl with or without therapy.

Exclusion Criteria:

  1. Binge eating disorder (Bulemia, Anorexia nervosa)
  2. Congestive heart failure NYHA Class >3
  3. >Stage 3 chronic kidney disease
  4. Cardiovascular disease (non-fatal MI, non-fatal stroke, peripheral vascular disease) within the past 6 months of screening
  5. Planned coronary artery, carotid artery or peripheral artery revascularization
  6. Weight loss surgery (gastric bypass, sleeve gastrectomy, total/subtotal gastrectomy) within the past 2 yrs.
  7. Pregnant and lactating females
  8. Active malignancy

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    No Intervention

    Experimental

    Arm Label

    OPTIFAST only

    UPMC PFW followed by OPTIFAST

    Arm Description

    Control group will consist of participants that have not undergone behavioral modifications with the Prescription for Wellness Program. These are participants that only go through the OPTIFAST Program.

    The intervention group will consist of participants that have undergone behavioral modifications with the Prescription for Wellness Program. These are participants who undergo the Prescription for Wellness Program prior to the OPTIFAST Program.

    Outcomes

    Primary Outcome Measures

    Change from baseline in body weight at 6 months
    The degree of weight loss in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
    Change from 6 months in body weight at 18 months
    The duration of weight maintenance in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.

    Secondary Outcome Measures

    Change from baseline in blood pressure at 18 months
    change in blood pressure over time in participants who undergo behavioral interventions compared to those who do not.
    Change from baseline in A1c at 18 months
    change in A1c over time in participants who undergo behavioral interventions compared to those who do not.
    Change from baseline in lipid profile at 18 months
    change in lipid profile overtime in participants who undergo behavioral interventions compared to those who do not.
    Change from baseline in medication burden (number of medications) at 18 months
    Change in medication burden (number of medications) pertaining to type 2 DM and hypertension over time
    Change from baseline in medication burden (dose of medications) at 18 months
    Change in medication burden (dose of medications) pertaining to type 2 DM and hypertension over time

    Full Information

    First Posted
    December 4, 2019
    Last Updated
    June 22, 2020
    Sponsor
    University of Pittsburgh
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04190069
    Brief Title
    Effects of Behavioral Interventions on Weight Loss and Weight Maintenance
    Official Title
    Effects of Behavioral Interventions on Weight Loss and Weight Maintenance
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2020
    Overall Recruitment Status
    Withdrawn
    Why Stopped
    IRB recommended change to registry study or quality improvement project status
    Study Start Date
    January 2020 (Anticipated)
    Primary Completion Date
    December 2021 (Anticipated)
    Study Completion Date
    December 2022 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University of Pittsburgh

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    The objective of the study is to examine the extent to which diet/lifestyle change programs with a multidisciplinary team (consisting of a dietician, physician and behaviorist/health coach) that develop healthy behaviors before creating a calorie deficit for weight loss will result in greater weight loss and a longer duration of weight maintenance. It intends to compare the extent of weight loss and weight maintenance in participants who will undergo calorie restriction without prior behavioral interventions to participants that will undergo behavioral interventions prior to starting calorie restriction.
    Detailed Description
    OPTIFAST is a medically supervised weight loss and weight management program that involves a complete meal replacement followed by a gradual introduction of foods after dietary education. The resources offered through this program are through a physician, registered dietitian and behaviorist, including a psychologist. UPMC Prescription for Wellness is an innovative physician/provider prescribed coaching and feedback program that improves patient engagement and outcomes in healthy behaviors; self-care of chronic disease and condition management; and shared decision-making. The resources available through this program are offered via a telephonic health coach, online or through a digital intervention based on the participant's convenience. The objective of the study is to examine the extent to which diet/lifestyle change programs with a multidisciplinary team (consisting of a dietician, physician and behaviorist/health coach) that develop healthy behaviors before creating a calorie deficit for weight loss will result in greater weight loss and a longer duration of weight maintenance. It intends to compare the extent of weight loss and weight maintenance in participants who will undergo calorie restriction without prior behavioral interventions to participants that will undergo behavioral interventions prior to starting calorie restriction. Behavioral interventions will first be provided by UPMC Prescription for Wellness prior to starting OPTIFAST. Calorie restriction will be during the OPTIFAST Program. The participants will be actively recruited by the study team at the Center for Diabetes and Metabolism (CDE) at the Falk Clinic in Oakland, Pittsburgh.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Behavior
    Keywords
    weight loss, weight maintenance

    7. Study Design

    Primary Purpose
    Other
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    Non-Randomized
    Enrollment
    0 (Actual)

    8. Arms, Groups, and Interventions

    Arm Title
    OPTIFAST only
    Arm Type
    No Intervention
    Arm Description
    Control group will consist of participants that have not undergone behavioral modifications with the Prescription for Wellness Program. These are participants that only go through the OPTIFAST Program.
    Arm Title
    UPMC PFW followed by OPTIFAST
    Arm Type
    Experimental
    Arm Description
    The intervention group will consist of participants that have undergone behavioral modifications with the Prescription for Wellness Program. These are participants who undergo the Prescription for Wellness Program prior to the OPTIFAST Program.
    Intervention Type
    Behavioral
    Intervention Name(s)
    Behavioral interventions/modifications
    Intervention Description
    UPMC Prescription for Wellness is an innovative physician/provider prescribed coaching and feedback program that improves patient engagement and outcomes in healthy behaviors; self-care of chronic disease and condition management; and shared decision-making. The resources available through this program are offered via a telephonic health coach, online or through a digital intervention based on the participant's convenience.
    Primary Outcome Measure Information:
    Title
    Change from baseline in body weight at 6 months
    Description
    The degree of weight loss in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
    Time Frame
    6 months
    Title
    Change from 6 months in body weight at 18 months
    Description
    The duration of weight maintenance in those who undergo behavioral modifications prior to starting calorie restriction compared to those who do not undergo behavioral modifications prior to starting calorie restriction.
    Time Frame
    6 months vs 18 months
    Secondary Outcome Measure Information:
    Title
    Change from baseline in blood pressure at 18 months
    Description
    change in blood pressure over time in participants who undergo behavioral interventions compared to those who do not.
    Time Frame
    18 months
    Title
    Change from baseline in A1c at 18 months
    Description
    change in A1c over time in participants who undergo behavioral interventions compared to those who do not.
    Time Frame
    18 months
    Title
    Change from baseline in lipid profile at 18 months
    Description
    change in lipid profile overtime in participants who undergo behavioral interventions compared to those who do not.
    Time Frame
    18 months
    Title
    Change from baseline in medication burden (number of medications) at 18 months
    Description
    Change in medication burden (number of medications) pertaining to type 2 DM and hypertension over time
    Time Frame
    18 months
    Title
    Change from baseline in medication burden (dose of medications) at 18 months
    Description
    Change in medication burden (dose of medications) pertaining to type 2 DM and hypertension over time
    Time Frame
    18 months

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: Male or female aged 18 yrs or older BMI >40 kg/m2 BMI between 35-40 kg/m2 with obesity-related co-morbidities including type 2 diabetes mellitus, hypertension, dyslipidemia. Type 2 Diabetes Mellitus defined by A1c >6.4% with or without oral hypoglycemic agents and with or without insulin therapy. Hypertension defined by blood pressure >140/80 mm of hg with or without antihypertensive therapy. Dyslipidemia defined as fasting lipid profile with one or more of the following abnormalities: serum cholesterol levels >200 mg/dl, serum triglyceride levels >150 mg/dl, HDL levels <50 mg/dl, LDL levels >100 mg/dl with or without therapy. Exclusion Criteria: Binge eating disorder (Bulemia, Anorexia nervosa) Congestive heart failure NYHA Class >3 >Stage 3 chronic kidney disease Cardiovascular disease (non-fatal MI, non-fatal stroke, peripheral vascular disease) within the past 6 months of screening Planned coronary artery, carotid artery or peripheral artery revascularization Weight loss surgery (gastric bypass, sleeve gastrectomy, total/subtotal gastrectomy) within the past 2 yrs. Pregnant and lactating females Active malignancy
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    David Rometo, M.D
    Organizational Affiliation
    University of Pittsburgh
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Plan to Share IPD
    No

    Learn more about this trial

    Effects of Behavioral Interventions on Weight Loss and Weight Maintenance

    We'll reach out to this number within 24 hrs